1,3-dipropylxanthine has been researched along with mrs 1754 in 2 studies
Studies (1,3-dipropylxanthine) | Trials (1,3-dipropylxanthine) | Recent Studies (post-2010) (1,3-dipropylxanthine) | Studies (mrs 1754) | Trials (mrs 1754) | Recent Studies (post-2010) (mrs 1754) |
---|---|---|---|---|---|
26 | 0 | 0 | 30 | 0 | 13 |
Protein | Taxonomy | 1,3-dipropylxanthine (IC50) | mrs 1754 (IC50) |
---|---|---|---|
Adenosine receptor A2a | Homo sapiens (human) | 1 | |
Adenosine receptor A2b | Homo sapiens (human) | 0.032 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahern, DG; Jacobson, KA; Ji, X; Kim, YC; Linden, J | 1 |
Jacobson, KA; Kim, HS; Kim, SA; Linden, J; Marshall, MA; Melman, N; Müller, CE | 1 |
2 other study(ies) available for 1,3-dipropylxanthine and mrs 1754
Article | Year |
---|---|
[3H]MRS 1754, a selective antagonist radioligand for A(2B) adenosine receptors.
Topics: Acetamides; Cells, Cultured; Humans; Purinergic P1 Receptor Antagonists; Purines; Radioligand Assay; Radiopharmaceuticals; Receptor, Adenosine A2B; Tritium | 2001 |
Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions.
Topics: Animals; Binding, Competitive; Cell Line; Cloning, Molecular; Humans; Ligands; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2B; Receptors, Purinergic P1; Recombinant Proteins; Structure-Activity Relationship; Xanthines | 2002 |